SCOPUS 정보 검색 플랫폼

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 4, 2012, Pages 632-639

A computerized treatment algorithm trial to optimize mineral metabolism in ESRD

(5) Spiegel, David M a McPhatter, Lesley b Allison, Ann b Drumheller, Joanne C b Lockridge, Robert c

a UNIVERSITY OF COLORADO (United States)

b UNIVERSITY OF VIRGINIA (United States)

c Lynchburg Nephrology Associates (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D DERIVATIVE;

ADULT; ALGORITHM; ARTICLE; AUTOMATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; FEMALE; HEMODIALYSIS; HORMONAL REGULATION; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM;

AGED; ALGORITHMS; BIOLOGICAL MARKERS; CALCIMIMETIC AGENTS; CALCIUM; DRUG SUBSTITUTION; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; METABOLIC DISEASES; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHORUS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMINS;

EID: 84859557600 PISSN: 15559041 EISSN: 1555905X Source Type: Journal
DOI: 10.2215/CJN.08170811 Document Type: Article

Times cited : (4)

References (10)

1
- 68949114585
- Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic KidneyDisease-Mineral and BoneDisorder (CKD-MBD)
- Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic KidneyDisease-Mineral and BoneDisorder (CKD-MBD). Kidney Int Suppl (113): S1-S130, 2009
- (2009) Kidney Int Suppl , vol.113

2
- 83055172414
- National Kidney Foundation: KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
- National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S201, 2003
- (2003) Am J Kidney Dis , vol.42 , Issue.SUPPL. 3

3
- 11144353767
- Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
- Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1516-1525, 2004
- (2004) N Engl J Med , vol.350 , pp. 1516-1525
- Block, G.A.¹ Martin, K.J.² de Francisco, A.L.³ Turner, S.A.⁴ Avram, M.M.⁵ Suranyi, M.G.⁶ Hercz, G.⁷ Cunningham, J.⁸ Abu-Alfa, A.K.⁹ Messa, P.¹⁰ Coyne, D.W.¹¹ Locatelli, F.¹² Cohen, R.M.¹³ Evenepoel, P.¹⁴ Moe, S.M.¹⁵ Fournier, A.¹⁶ Braun, J.¹⁷ McCary, L.C.¹⁸ Zani, V.J.¹⁹ Olson, K.A.²⁰ Drüeke, T.B.²¹ Goodman, W.G.²² more..

4
- 19944430161
- Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl
- Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drüeke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ: Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67: 760-771, 2005
- (2005) Kidney Int , vol.67 , pp. 760-771
- Moe, S.M.¹ Chertow, G.M.² Coburn, J.W.³ Quarles, L.D.⁴ Goodman, W.G.⁵ Block, G.A.⁶ Drüeke, T.B.⁷ Cunningham, J.⁸ Sherrard, D.J.⁹ McCary, L.C.¹⁰ Olson, K.A.¹¹ Turner, S.A.¹² Martin, K.J.¹³

5
- 46849091357
- TARGET Investigators: Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism
- Block GA, Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA; TARGET Investigators: Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant 23: 2311-2318, 2008
- (2008) Nephrol Dial Transplant , vol.23 , pp. 2311-2318
- Block, G.A.¹ Zeig, S.² Sugihara, J.³ Chertow, G.M.⁴ Chi, E.M.⁵ Turner, S.A.⁶ Bushinsky, D.A.⁷

6
- 33746207542
- CONTROL Investigators: Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate
- Chertow GM, Blumenthal S, Turner S, Roppolo M, Stern L, Chi EM, Reed J; CONTROL Investigators: Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. Clin J Am Soc Nephrol 1: 305-312, 2006
- (2006) Clin J Am Soc Nephrol , vol.1 , pp. 305-312
- Chertow, G.M.¹ Blumenthal, S.² Turner, S.³ Roppolo, M.⁴ Stern, L.⁵ Chi, E.M.⁶ Reed, J.⁷

7
- 38749101028
- The OPTIMA study: Assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism
- Messa P, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Wilkie M, Zani VJ, Molemans B, Carter D, Locatelli F: The OPTIMA study: Assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism. Clin J Am Soc Nephrol 3: 36-45, 2008
- (2008) Clin J Am Soc Nephrol , vol.3 , pp. 36-45
- Messa, P.¹ Macário, F.² Yaqoob, M.³ Bouman, K.⁴ Braun, J.⁵ von Albertini, B.⁶ Brink, H.⁷ Maduell, F.⁸ Graf, H.⁹ Frazão, J.M.¹⁰ Bos, W.J.¹¹ Torregrosa, V.¹² Saha, H.¹³ Reichel, H.¹⁴ Wilkie, M.¹⁵ Zani, V.J.¹⁶ Molemans, B.¹⁷ Carter, D.¹⁸ Locatelli, F.¹⁹

8
- 79952280308
- Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients-results of the Austrian cohort of the ECHOstudy
- Zitt E, Jäger C, Rosenkranz AR, Eigner M, Kodras K, Kovarik J, Graf H, Pétavy F, Horn S, Watschinger B: Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients-results of the Austrian cohort of the ECHOstudy. Wien Klin Wochenschr 123: 45-52, 2011
- (2011) Wien Klin Wochenschr , vol.123 , pp. 45-52
- Zitt, E.¹ Jäger, C.² Rosenkranz, A.R.³ Eigner, M.⁴ Kodras, K.⁵ Kovarik, J.⁶ Graf, H.⁷ Pétavy, F.⁸ Horn, S.⁹ Watschinger, B.¹⁰

9
- 79959607346
- Use of cinacalcet in clinical practice for the treatment of secondary hyperparathyroidism: Analysis of the Italian data of the ECHO study
- Malberti F, Albertazzi A, Garibotto G, Papagni S, Sicurezza E, Gambini F, Piccolo C: [Use of cinacalcet in clinical practice for the treatment of secondary hyperparathyroidism: Analysis of the Italian data of the ECHO study]. G Ital Nefrol 28: 201-209, 2011
- (2011) G Ital Nefrol , vol.28 , pp. 201-209
- Malberti, F.¹ Albertazzi, A.² Garibotto, G.³ Papagni, S.⁴ Sicurezza, E.⁵ Gambini, F.⁶ Piccolo, C.⁷

10
- 34548821615
- Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and design overview
- Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P: Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and design overview. Clin J AmSoc Nephrol 2: 898-905, 2007
- (2007) Clin J AmSoc Nephrol , vol.2 , pp. 898-905
- Chertow, G.M.¹ Pupim, L.B.² Block, G.A.³ Correa-Rotter, R.⁴ Drueke, T.B.⁵ Floege, J.⁶ Goodman, W.G.⁷ London, G.M.⁸ Mahaffey, K.W.⁹ Moe, S.M.¹⁰ Wheeler, D.C.¹¹ Albizem, M.¹² Olson, K.¹³ Klassen, P.¹⁴ Parfrey, P.¹⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.